Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 September 2019 | Story Leonie Bolleurs | Photo Leonie Bolleurs
student dialogue
Dialogues presented by the Office for International Affairs provide a safe space for people to voice their opinions, to learn, and to engage. Here are, from the left: Montsi Ramonaheng, third-year BSc student majoring in Biochemistry and Genetics; Lebohang Lesenyeno, third-year LLB student; Motsaathebe Serekoane, Lecturer in Anthropology; and Bulelwa Moikwatlhai from the Office for International Affairs.

Will the creation of one African country solve the problem of xenophobia? 

This was the question raised at a recent dialogue session on the University of the Free State Bloemfontein Campus.

Most attendees believed the concept of ‘one Africa’ implied that only one language and one dominant culture would be needed – resulting in the spirit of multiculturalism ceasing to exist. When one speaks of a united Africa, it means that the continent recognises the diversity of its cultures and embraces these diversities. It was concluded that one Africa was not a solution to ending xenophobia.

Awareness of xenophobia from a human rights perspective

The Office for International Affairs hosted the two-dialogue series aimed at addressing an array of social issues such as xenophobia, cultural appropriation, and xenocentrism. They wanted to demonstrate the influence these issues have – not only on the mindsets of individuals, but also on how it can contribute towards the development of an unjust society devoid of embracing difference.

The first session was titled: Burn the Phobia, with the theme: ‘We are all foreigners somewhere’. The aim of this dialogue was to create awareness of xenophobia from a human rights perspective. 

Recently, a second dialogue session was presented, with the theme ‘Appropriation vs Xenocentrism’. According to Bulelwa Moikwatlhai, Officer in the Office for International Affairs, the purpose of this session was to encourage people to appreciate their own cultures and to respect other peoples’ cultures.

“We wanted to critically discuss cultural appropriation versus xenocentrism in an attempt to find a human response that is inclusive in nature,” says Moikwatlhai.

Direct outflow of UFS Integrated Transformation Plan

The lecture was presented by Motsaathebe Serekoane, Lecturer in the Department of Anthropology at the UFS, who urged attendees to always keep it authentic. He also stated that, as boundaries between the North and the South collapsed and knowledge flowed in and out, knowledge from the South was not taken seriously. 

“We lost ourselves within what happened in the North. We want to be appropriate and we want what they have, because it is more beautiful than what we have. We need to find something in Africa that will define us as African,” he says. 

These dialogues are a build-up to the International Cultural Diversity Festival that will take place at the Thakaneng Bridge on 13 September 2019 from 12:00 to 14:00.

The dialogue is a direct outflow of the university’s Integrated Transformation Plan. “We strive to cultivate a culture where everyone feels welcome and comfortable. We want to create common ground for international and South African students to get together and to collaboratively discuss issues from both parties in order to find innovative solutions to student challenges,” indicates Moikwatlhai.

Much of what is learnt in these sessions is used for reflection in order to improve the overall student experience. According to Miokwatlhai, it is essential to ensure that all processes related to students are structured to be socially just and inclusive. 

“As an institution of higher learning, we need to continuously create such platforms so that we have rich engagements about pertinent issues that affect the UFS community, and find human solutions to overcome barriers,” she concludes.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept